SIGA TECHNOLOGIES INC. - COMMON STOCK

SIGA Announces Oncology Collaboration with KaliVir Immunotherapeutics

15 يوليو 2022 06:30:00 بحسب Nasdaq GlobeNewswire

SIGA Announces Approximately $28 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)

12 يوليو 2022 15:15:00 بحسب Nasdaq GlobeNewswire

SIGA Technologies Receives Approval from UK for Tecovirimat

08 يوليو 2022 06:30:00 بحسب Nasdaq GlobeNewswire

SIGA Announces $13 Million of International Procurement Orders for Oral TPOXX® (Tecovirimat)

23 يونيو 2022 07:00:01 بحسب Nasdaq GlobeNewswire

SIGA to Participate in Alliance Global Partners’ Monkeypox Panel on Thursday, June 23rd 2022

22 يونيو 2022 09:13:44 بحسب Nasdaq GlobeNewswire

SIGA Receives Approval from the FDA for Intravenous (IV) Formulation of TPOXX® (tecovirimat)

19 مايو 2022 06:30:00 بحسب Nasdaq GlobeNewswire

New Contract Awarded by U.S. Department of Defense for the Procurement of up to Approximately $7.5 Million of Oral TPOXX®

12 مايو 2022 15:05:01 بحسب Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three Months Ended March 31, 2022

05 مايو 2022 15:05:02 بحسب Nasdaq GlobeNewswire

SIGA Declares Special Dividend of $0.45 Per Share

05 مايو 2022 06:30:01 بحسب Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on May 5th, 2022 Following Release of First Quarter 2022 Financial Results

28 أبريل 2022 15:05:02 بحسب Nasdaq GlobeNewswire

SIGA Reports Financial Results for Three and Twelve Months Ended December 31, 2021

03 مارس 2022 15:05:01 بحسب Nasdaq GlobeNewswire

SIGA Announces Start of TPOXX® Post-Exposure Prophylactic (“PEP”) Clinical Trials

02 مارس 2022 06:30:00 بحسب Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on March 3rd, 2022 Following Release of Fourth Quarter and Full Year 2021 Financial Results

24 فبراير 2022 09:27:12 بحسب Nasdaq GlobeNewswire

SIGA Announces Preclinical Oncology Research Collaboration with Bioarchitech

25 يناير 2022 06:30:00 بحسب Nasdaq GlobeNewswire

SIGA Technologies to Participate in Edison Group’s Global Healthcare “Open House” Virtual Conference from January 25-27th, 2022

18 يناير 2022 06:30:00 بحسب Nasdaq GlobeNewswire

SIGA Technologies Receives Approval from the European Medicines Agency for Tecovirimat

10 يناير 2022 06:30:00 بحسب Nasdaq GlobeNewswire

SIGA Announces Health Canada Regulatory Approval of Oral TPOXX®

01 ديسمبر 2021 08:55:02 بحسب Nasdaq GlobeNewswire

European Medicines Agency Committee for Medicinal Products for Human Use (CHMP) Recommends Approval of Tecovirimat

16 نوفمبر 2021 07:30:00 بحسب Nasdaq GlobeNewswire

SIGA Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2021

04 نوفمبر 2021 15:05:01 بحسب Nasdaq GlobeNewswire

SIGA Technologies to Host Business Update Call on November 4th, 2021, Following Release of Third Quarter 2021 Financial Results

28 أكتوبر 2021 15:15:00 بحسب Nasdaq GlobeNewswire